Patents by Inventor Mikael Danfelter

Mikael Danfelter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnosis of collagen IX destruction
    Patent number: 8580529
    Abstract: A method for detecting or monitoring the presence of protein fragments, cleaved at novel cleaving sites near the N-terminal part of the collagen IX alpha 1 chain, close to the C-terminal part of the NC4 domain, and at the COL3 domain close to the NC3 domain. Neoepitope antibodies against the neoepitopes were created by the cleavages and an epitope in the cleaved N-terminal part of the NC4 domain unique to collagen IX. A diagnostic kit and antibodies useful in carrying out such methods are also presented.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: November 12, 2013
    Assignee: AnaMar AB
    Inventors: Mikael Danfelter, Patrik Önnerfjord, Dick Heinegård
  • Diagnosis of collagen IX destruction
    Publication number: 20110144310
    Abstract: A method for detecting or monitoring the presence of protein fragments, cleaved at novel cleaving sites near the N-terminal part of the collagen IX alpha 1 chain, close to the C-terminal part of the NC4 domain, and at the COL3 domain close to the NC3 domain. Neoepitope antibodies against the neoepitopes were created by the cleavages and an epitope in the cleaved N-terminal part of the NC4 domain unique to collagen IX.
    Type: Application
    Filed: December 22, 2010
    Publication date: June 16, 2011
    Inventors: Mikael Danfelter, Patrik Onnerfjord
  • Diagnosis of collagen IX destruction
    Patent number: 7892768
    Abstract: A method for detecting or monitoring the presence of protein fragments, cleaved at novel cleaving sites near the N-terminal part of the collagen IX alpha 1 chain, close to the C-terminal part of the NC4 domain, and at the COL3 domain close to the NC3 domain. Neoepitope antibodies against the neoepitopes were created by the cleavages and an epitope in the cleaved N-terminal part of the NC4 domain unique to collagen IX. A diagnostic kit and antibodies useful in carrying out such methods are also presented.
    Type: Grant
    Filed: February 26, 2008
    Date of Patent: February 22, 2011
    Assignee: Anamar Medical AB
    Inventors: Mikael Danfelter, Patrik Önnerfjord, Dick HeinegÅrd
  • Diagnosis of collagen IX destruction
    Publication number: 20080220459
    Abstract: A method for detecting or monitoring the presence of protein fragments, cleaved at novel cleaving sites near the N-terminal part of the collagen IX alpha 1 chain, close to the C-terminal part of the NC4 domain, and at the COL3 domain close to the NC3 domain. Neoepitope antibodies against the neoepitopes were created by the cleavages and an epitope in the cleaved N-terminal part of the NC4 domain unique to collagen IX.
    Type: Application
    Filed: February 26, 2008
    Publication date: September 11, 2008
    Inventors: Mikael Danfelter, Patrik Onnerfjord, Dick Heinegard